The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
复制标题
DOI:
10.1158/0008-5472.can-10-0475
复制
发表时间:
2010-08-15
期刊:
影响因子:
11.2
通讯作者:
Monnat RJ
中科院分区:
文献类型:
--
作者:
Mao FJ;Sidorova JM;Lauper JM;Emond MJ;Monnat RJ
Loss of function mutations in the human RecQ helicase genes WRN and BLM respectively cause the genetic instability/cancer predisposition syndromes Werner syndrome and Bloom syndrome. In order to identify common and unique functions of WRN and BLM, we systematically analyzed cell proliferation, cell survival and genomic damage in isogenic cell lines depleted of WRN, BLM or both proteins. Cell proliferation and survival were assessed prior to and after treatment with camptothecin, cis-Pt, hydroxyurea or 5-fluorouracil. Genomic damage was assessed, prior to and after replication arrest, by γ-H2AX staining quantified at the single cell level by flow cytometry. Cell proliferation was strongly affected by the extent of WRN and/or BLM depletion, and more strongly by BLM than by WRN depletion (p=0.005). The proliferation of WRN/BLM co-depleted cells, in contrast, did not differ from BLM-depleted cells (p=0.34). BLM-depleted and WRN/BLM co-depleted cells had comparably impaired survivals after DNA damage, whereas WRN-depleted cells displayed a distinct pattern of sensitivity to DNA damage. BLM-depleted and WRN/BLM co-depleted cells had similar, significantly higher γ-H2AX induction levels than did WRN-depleted cells. Our results provide new information on the role of WRN and BLM in determining cell proliferation, cell survival and genomic damage after chemotherapeutic DNA damage or replication arrest. We also provide new information on functional redundancy between WRN and BLM. These results provide a strong rationale for further developing WRN and BLM as biomarkers of tumor chemotherapeutic responsiveness.